相关实验视频
Updated: Jun 11, 2025
06:39
Real-Time Void Spot Assay
Published on: February 10, 2023
1.9K
美国女性膀过活和药物治疗的趋势
Lauren A King1, Jessica E Pruszynski2, Clifford Y Wai3
1From the Department of Obstetrics and Gynecology and.
Urogynecology (Philadelphia, Pa.)
|September 27, 2024
概括
过度活性膀 (OAB) 的患病率正在增加,特别是在老年妇女中,但药物治疗仍然很低. 这突显了OAB症状管理中的重大差距,并表明需要增加查和干预.
科学领域:
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 药理学 药理学是指药理学的学科.
- 公共卫生 公共卫生
背景情况:
- 过度活跃的膀 (OAB) 影响着相当一部分人口,随着时间的推移,患病率会增加.
- 目前对症状性OAB的药物治疗率似乎很低,这表明潜在的治疗不足.
- 了解OAB患病率和治疗趋势对于公共卫生倡议至关重要.
研究的目的:
- 评估美国过度活动膀 (OAB) 患病率的趋势.
- 分析随着时间的推移对OAB药物的药理学处方实践的变化.
- 在不同的人口群体中识别OAB患病率和治疗的差异.
主要方法:
- 利用了2001-2019年国家健康和营养检查调查 (NHANES) 和国家门诊医疗调查 (NAMCS) 的数据.
- 雇员结合点回归分析OAB患病率和药物处方的趋势,调整关键的人口因素.
- 评估了总体趋势,并按种族,年龄,体重指数和保险状况分层.
主要成果:
- 整体而言,OAB患病率增加 (APC 1.24%),在2017-2018年达到31.2%,65岁以上女性的患病率最高 (54%).
- 药物治疗仍然很低 (3.5%的症状患者).
- 根据NAMCS数据,抗胆固醇药物处方显著下降 (APC -6.44%),而β3-上腺激素激剂处方保持稳定.
结论:
- 随着OAB的患病率上升,尤其是老年女性,再加上治疗率较低,表明治疗不足显著.
- 对于有症状的OAB患者,急需加强查和及时干预.
- 对OAB药物的处方模式正在发生变化,抗胆固醇药物的使用有显著下降.
相关概念视频
01:30Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
2
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
2
01:21Nursing Assessment of the Genitourinary System I: Health History
2
The genitourinary system is critical to maintaining fluid balance, waste elimination, and reproductive function. Nurses play a vital role in assessing this system, beginning with a thorough health history. This process involves gathering patient information, identifying risk factors, and recognizing symptoms of genitourinary disorders. Early detection is vital for timely interventions and management.1. Gathering Patient InformationA complete health history includes the patient’s personal,...
2
01:17Urinary Tract Infection IV: Nursing Management
2
In managing urinary tract infections (UTIs) in nursing, a comprehensive assessment is essential. Begin by gathering subjective data, such as the patient’s complaints of dysuria (painful urination), urinary frequency, urgency, suprapubic pain, and any lower abdominal discomfort. This information can be complemented by questions regarding previous UTIs, sexual activity, and personal hygiene practices, which can provide insight into risk factors. Objective assessment should focus on signs...
2
01:17Drugs for Treatment of Diarrhea-Predominant IBS
151
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
151
01:30Irritable Bowel Syndrome III: Medical and Nursing Management
174
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
174
01:21Drugs for Treatment of Constipation-Predominant IBS
140
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
140